$8.600
+0.184 (+2.14%)At close
RYAM News
RYAM Events
Rayonier Advanced Materials Appoints Daniel Krawczyk as CEO
Rayonier Advanced Materials announced that the Board of Directors has appointed Daniel Krawczyk as CEO and President. He will also join the Company's Board of Directors. Krawczyk will be responsible for leading RYAM's operations and business activities while working closely with the Board and its external advisors as part of RYAM's exploration of strategic alternatives to maximize shareholder value. Krawczyk most recently served as President of Huber Engineered Materials. Prior to Krawczyk's appointment, the Board had formed an interim Office of the CEO, comprising current executives including Marcus Moeltner, CFO and SVP of Finance; Michael Osborne, VP of Manufacturing Operations; Christian Ribeyrolle, SVP of Biomaterials; and R. Colby Slaughter, SVP, General Counsel and Corporate Secretary. Members of the now disbanded Office of the CEO will continue in their prior roles and will work closely with Krawczyk to continue to execute RYAM's business priorities as part of the senior leadership team.
Company Board Actively Evaluates Strategic Alternatives
The company said, "The Board continues to actively evaluate a broad range of strategic alternatives with the assistance of Morgan Stanley. The review process is well underway, and the Board is actively advancing the process with urgency and discipline. The Board's appointment of a new CEO further sharpens the focus on both the business and the strategic review. No conclusions have been reached, and the appointment should not be viewed as signaling any particular outcome of the review. The Board remains committed to pursuing the path that it believes will maximize shareholder value."
Mill Pond Capital Urges Rayonier to Conduct Full Sale
Mill Pond Capital, which owns approximately 3% of the outstanding common shares of Rayonier Advanced Materials, sent a letter to the company's Board of Directors urging the Board to conduct a full sale of RYAM. In the letter, Daniel Farb, Managing Member of Mill Pond Capital, stated in part, "I first became a shareholder of Rayonier Advanced Materials in 2019 and currently own approximately 3% of the company's outstanding common shares, making me one of the company's larger shareholders. I have a successful history of investing in commodity-related businesses and, like each of you on RYAM's Board of Directors, have served on public company boards in the commodity space. I am writing today following a private letter I sent on May 8, 2026, and a subsequent call with Chair Dill, in which I stated my belief that a full sale of RYAM is the best path forward for the company. This limited engagement from Chair Dill produced only the assurance that the Board is 'working to do what is best for shareholders.' After seven years of receiving that assurance - and being unable to present my views to the broader Board - I am no longer content to wait for a different result."
Q1 Revenue Reaches $319M, Exceeds Expectations
Reports Q1 revenue $319M, consensus $302.63M. "Our first quarter performance was consistent with the trajectory we outlined in March, with early progress on pricing and mix in Cellulose Specialties and positive adjusted free cash flow despite a low earnings base," said Marcus Moeltner, Office of the CEO, Chief Financial Officer and Senior Vice President of Finance.
Rayonier Advanced Materials Engages in Strategic Alternatives Review
Rayonier Advanced Materials announced that the Company is engaged in a formal process to explore strategic alternatives to maximize shareholder value. In connection with the strategic alternatives review, the Company has engaged Morgan Stanley & Co. as its financial advisor and Wachtell, Lipton, Rosen & Katz as its legal counsel. The strategic review will consider a range of potential strategic, business and financial alternatives, which may include, among other things, a sale of all or part of the Company, a strategic investment, a merger or other business combination, or other strategic or financial alternatives, as well as continuing to execute on the Company's standalone strategic plan. The Board remains confident that its approach-which is grounded in disciplined governance, transparency, and a commitment to sustainable value creation-is in the best interests of stockholders, customers, employees and all stakeholders. The Board has not set a timetable for completion of the strategic review and does not intend to provide updates unless and until it is determined that disclosure is appropriate or required by law. There can be no assurance that the strategic alternatives review process will result in any transaction or other strategic change.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.